ArticleBMC cancer2023

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma.

Zi-Tao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.